Antitumor activity of the novel vascular targeting agent ZD6126 in a panel of tumor models.

類似資料

• ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature.
  著者:: Davis, P, 等
  出版事項: (2002)
• Antitumor effect of the vascular-disrupting agent ZD6126 in a murine renal cell carcinoma model.
  著者:: Medinger, M, 等
  出版事項: (2011)
• Liposomal encapsulation enhances the antitumour efficacy of the vascular disrupting agent ZD6126 in murine B16.F10 melanoma.
  著者:: Fens, M, 等
  出版事項: (2008)
• Impact of tumor cell VEGF expression on the in vivo efficacy of vandetanib (ZACTIMA; ZD6474).
  著者:: Siemann, D, 等
  出版事項: (2009)
• Stereochemical control of nucleosome targeting by platinum-intercalator antitumor agents
  著者:: Chin, Chee Fei, 等
  出版事項: (2015)